Idarubicin plus cytarabine as first-line treatment of acute nonlymphoblastic leukemia

Semin Oncol. 1989 Feb;16(1 Suppl 2):16-20.
No abstract available

MeSH terms

  • Adolescent
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cytarabine / administration & dosage
  • Cytarabine / adverse effects
  • Female
  • Humans
  • Idarubicin / administration & dosage
  • Idarubicin / adverse effects
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / mortality
  • Leukocyte Count / drug effects
  • Male
  • Middle Aged
  • Remission Induction

Substances

  • Cytarabine
  • Idarubicin